Larvol Delta - MacroGenics-Announces-Updated-Efcacy-amp-Safety-Data-from-TAMARACK-Phase-2-Study-of-Vobra-Duo-in-mCRPC-Patients-at-ESMO-Congress-2024

vobramitamab duocarmazine (MGC018) - MacroGenics

https://www.globenewswire.com/news-release/2024/09/15/2946281/0/en/MacroGenics-Announces-Updated-Efficacy-Safety-Data-from-TAMARACK-Phase-2-Study-of-Vobra-Duo-in-mCRPC-Patients-at-ESMO-Congress-2024.html

Sep 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next